You’ve been diagnosed with stage I-IIIA hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer. Now, you have treatment choices to make. Do you really need chemotherapy, or is your cancer likely to respond to hormone therapy alone? Your doctor has ordered the Breast Recurrence Score® test to help you find out.
Personalized insights for personalized treatment
Just as every patient is different, so is every tumor. The Breast Recurrence Score test uses genomics to give you and your doctor important risk information about how your individual tumor will likely behave. Valuable insights include:
- How likely you are to benefit from chemotherapy
- How likely your tumor is to spread
- The risk of your cancer recurring
- How likely your tumor is to benefit from hormone therapy alone